Cocaine self-administration produces pharmacodynamic tolerance: Differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate

Neuropsychopharmacology

Volumn 37, Issue 7, 2012, Pages 1708-1716

  Ferris, Mark J ^a   Calipari, Erin S ^a   Mateo, Yolanda ^a,b   Melchior, James R ^a   Roberts, David Cs ^a   Jones, Sara R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

cocaine; dopamine; dopamine transporter; methylphenidate; self administration; voltammetry

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMFEBUTAMONE; AMPHETAMINE; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE; METHYLPHENIDATE; NOMIFENSINE; PHENTERMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINE UPTAKE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG SELF ADMINISTRATION; DRUG TOLERANCE; MALE; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; RAT;

ANIMALS; BUPROPION; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; MALE; METHYLPHENIDATE; NOMIFENSINE; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION;

EID: 84861190024     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.17     Document Type: Article

References (51)

1. Ahmed SH, Koob GF (1998). Transition from moderate to excessive drug intake: change in hedonic set point. Science 282: 298-300. (Pubitemid 28487203)
2. Ahmed SH, Koob GF (1999). Long-lasting increase in the set point for cocaine self-administration after escalation in rats. Psychopharmacology 146: 303-312. (Pubitemid 29480242)
3. Androutsellis-Theotokis A, Rudnick G (2002). Accessibility and conformational coupling in serotonin transporter predicted internal domains. J Neurosci 22: 8370-8378. (Pubitemid 35387577)
4. Beaulieu JM, Gainetdinov RR (2011). The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63: 182-217.
5. Carelli RM, Deadwyler SA (1996). Dose-dependent transitions in nucleus accumbens cell firing and behavioral responding during cocaine self-administration sessions in rats. J Pharmacol Exp Therap 277: 385-393. (Pubitemid 27169084)
6. Chefer VI, Zakharova I, Shippenberg TS (2003). Enhanced responsiveness to novelty and cocaine is associated with decreased basal dopamine uptake and release in the nucleus accumbens: quantitative microdialysis in rats under transient conditions. J Neurosci 23: 3076-3084. (Pubitemid 36418643)
7. Chen NH, Reith MEA (2004). Interaction between dopamine and its transporter: role of intracellular sodium ions and membrane potential. J Neurochem 89: 750-765.
8. Chen R, Furman CA, Zhang MJ, Kim MN, Gereau RW, Leitges M et al (2009). Protein kinase C beta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice. J Pharmacol Exp Therap 328: 912-920.
9. Collins SL, Izenwasser S (2002). Cocaine differentially alters behavior and neurochemistry in periadolescent versus adult rats. Brain Res Dev Brain Res 138: 27-34. (Pubitemid 35253966)
10. Corera AT, Do-Rego JC, Costentin J, Bonnet JJ (2001). Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes. Neurosci Res 39: 319-325. (Pubitemid 32186384)
11. Dackis CA, O'Brien CP (2001). Cocaine dependence: a disease of the brain's reward centers. J Subst Abuse Treat 21: 111-117. (Pubitemid 33109059)
12. Dar DE, Mayo C, Uhl GR (2005). The interaction of methylphenidate and benztropine with the dopamine transporter is different than other substrates and ligands. Biochem Pharmac 70: 461-469. (Pubitemid 40905118)
13. Daws LC, Callaghan PD, Moron JA, Kahlig KM, Shippenberg TS, Javitch JA et al (2002). Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem Biophys Res Commun 290: 1545-1550. (Pubitemid 34687434)
14. Farnsworth SJ, Volz TJ, Hanson GR, Fleckenstein AE (2009). Cocaine alters vesicular dopamine sequestration and potassiumstimulated dopamine release: role of D2 receptor activaion. J Pharmacol Exp Ther 328: 807-812.
15. Ferris MJ, Mateo Y, Roberts DCS, Jones SR (2011). Cocaineinsensitive dopamine transporters with intact substrate transport produced by self-administration. Biolog Psychiatry 69: 201-207.
16. Foster JD, Adkins SD, Lever JR, Vaughan RA (2008). Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol. J Neurochem 105: 1683-1699. (Pubitemid 351678491)
17. Grabowski J, Shearer J, Merrill J, Negus SS (2004). Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 29: 1439-1464. (Pubitemid 39172183)
18. Hurd YL, Weiss F, Koob GF, And NE, Ungerstedt U (1989). Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbensFan in vivo Microdialysis Study. Brain Res 498: 199-203. (Pubitemid 19228184)
19. John CE, Jones SR (2007). Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. Neuropharmacology 52: 1596-1605. (Pubitemid 46843135)
20. Jones SR, Garris PA, Wightman RM (1995). Different effects of cocaine and nomifensine on dopamine uptake in the caudate- putamen and nucleus-accumbens. J Pharmacol Exp Therap 274: 396-403.
21. Karila L, Reynaud M, Aubin HJ, Rolland B, Guardia D, Cottencin O et al (2011). Pharmacological treatments for cocaine dependence: Is there something new? Curr Pharmaceut Des 17: 1359-1368.
22. Kennedy RT, Jones SR, Wightman RM (1992). Dynamic observation of dopamine autoreceptor effects in rat striatal slices. J Neurochem 59: 449-455.
23. Kuhar MJ, Ritz MC, Boja JW (1991). The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14: 299-302.
24. Lack CM, Jones SR, Roberts DCS (2008). Increased breakpoints on a progressive ratio schedule reinforced by IV cocaine are associated with reduced locomotor activation and reduced dopamine efflux in nucleus accumbens shell in rats. Psychopharmacology 195: 517-525. (Pubitemid 350161771)
25. Mandt BH, Zahniser NR (2010). Low and high cocaine locomotor responding male Sprague-Dawley rats differ in rapid cocaineinduced regulation of striatal dopamine transporter function. Neuropharmacology 58: 605-612.
26. Marusich JA, Beckmann JS, Gipson CD, Bardo MT (2010). Methylphenidate as a reinforcer for rats: contingent delivery and intake escalation. Exp Clin Psychopharmacol 18: 257-266.
27. Mateo Y, Lack CM, Morgan D, Roberts DCS, Jones SR (2005). Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation. Neuropsychopharmacology 30: 1455-1463. (Pubitemid 41153117)
28. Mendelson JH, Sholar M, Mello NK, Teoh SK, Sholar JW (1998). Cocaine tolerance: behavioral, cardiovascular, and neuroendocrine function in men. Neuropsychopharmacology 18: 263-271. (Pubitemid 28085525)
29. Negus SS, Baumann MH, Rothman RB, Mello NK, Blough BE (2009). Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in Rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine. J Pharmacol Exp Therap 329: 272-281.
30. Negus SS, Mello NK, Blough BE, Baumann MH, Rothman RB (2007). Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate ''agonist'' medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys. J Pharmacol Exp Therap 320: 627-636. (Pubitemid 46147942)
31. Peoples LL, Gee F, Bibi R, West MO (1998). Phasic firing time locked to cocaine self-infusion and locomotion: dissociable firing patterns of single nucleus accumbens neurons in the rat. J Neurosci 18: 7588-7598. (Pubitemid 28425840)
32. Peraile I, Torres E, Mayado A, Izco M, Lopez-Jimenez A, Lopez- Moreno JA et al (2010). Dopamine transporter down-regulation following repeated cocaine: implications for 3,4-methylenedioxymethamphetamine- induced acute effects and long-term neurotoxicity in mice. Br J Pharmacol 159: 201-211.
33. Ramamoorthy S, Samuvel DJ, Balasubramaniam A, See RE, Jayanthi LD (2010). Altered dopamine transporter function and phosphorylation following chronic cocaine self-administration and extinction in rats. Biochem Biophys Res Commun 391: 1517-1521.
34. Reed SC, Haney M, Evans SM, Vadhan NP, Rubin E, Foltin RW (2009). Cardiovascular and subjective effects of repeated smoked cocaine administration in experienced cocaine users. Drug Alcohol Depend 102: 102-107.
35. Richardson NR, Roberts DCS (1996). Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66: 1-11. (Pubitemid 26180064)
36. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987). Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223. (Pubitemid 17131228)
37. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1988). Cocaine selfadministration appears to be mediated by dopamine uptake inhibition. Progr Neuro-Psychopharmacol Biol Psychiatry 12: 233-239.
38. Rothman RB, Blough BE, Baumann MH (2008). Dopamine/ serotonin releasers as medications for stimulant addictions. Serotonin 172: 385-406.
39. Sabol KE, Seiden LS (1998). Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis. Brain Res 806: 69-78. (Pubitemid 29009575)
40. Self DW, Choi KH, Simmons D, Walker JR, Smagula CS (2004). Extinction training regulates neuroadaptive responses to withdrawal from chronic cocaine self-administration. Learn Mem 11: 648-657. (Pubitemid 39299717)
41. Shan JF, Javitch JA, Shi L, Weinstein H (2011). The substratedriven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter. PLoS One 6: e16350.
42. Shaw SY, Shah L, Jolly AM, Wylie JL (2008). Identifying heterogeneity among injection drug users: a cluster analysis approach. Am J Pub Health 98: 1430-1437.
43. Sonders MS, Amara SG (1997). Pharmacological agents as functional probes of the human dopamine transporter. Biophys J 72: TH357.
44. Teter CJ, Mccabe SE, LaGrange K, Cranford JA, Boyd CJ (2006). Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 26: 1501-1510. (Pubitemid 44521735)
45. Todtenkopf MS, De Leon KR, Stellar JR (2000). Repeated cocaine treatment alters tyrosine hydroxylase in the rat nucleus accumbens. Brain Res Bull 52: 407-411. (Pubitemid 30462212)
46. Ukairo OT, Bondi CD, Newman AH, Kulkarni SS, Kozikowski AP, Pan S et al (2005). Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue. J Pharmacol Exp Therap 314: 575-583. (Pubitemid 41051016)
47. Venton BJ, Seipel AT, Phillips PEM, Wetsel WC, Gitler D, Greengard P et al (2006). Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci 26: 3206-3209.
48. Wayment HK, Deutsch H, Schweri MM, Schenk JO (1999). Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists? J Neurochem 72: 1266-1274. (Pubitemid 29085043)
49. Wightman RM, Amatore C, Engstrom RC, Hale PD, Kristensen EW, Kuhr WG et al (1988). Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25: 513-523.
50. Wu Q, Reith MEA, Wightman RM, Kawagoe KT, Garris PA (2001). Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J Neurosci Methods 112: 119-133. (Pubitemid 33051114)
51. Yorgason JT, Espana RA, Jones SR (2011). Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J Neurosci Methods 202: 158-164.